rs6464816

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1778-32339G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 152,004 control chromosomes in the GnomAD database, including 2,048 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2048 hom., cov: 33)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.479

Publications

6 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1778-32339G>A intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.1778-32339G>A intron_variant Intron 11 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1778-32339G>A intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3
CNTNAP2ENST00000636870.1 linkn.1640-32339G>A intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1261-32339G>A intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1681-32339G>A intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.154
AC:
23317
AN:
151884
Hom.:
2045
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0901
Gnomad AMI
AF:
0.0868
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.183
Gnomad MID
AF:
0.188
Gnomad NFE
AF:
0.166
Gnomad OTH
AF:
0.169
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.153
AC:
23326
AN:
152004
Hom.:
2048
Cov.:
33
AF XY:
0.157
AC XY:
11671
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.0900
AC:
3731
AN:
41464
American (AMR)
AF:
0.198
AC:
3018
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
364
AN:
3470
East Asian (EAS)
AF:
0.321
AC:
1653
AN:
5152
South Asian (SAS)
AF:
0.176
AC:
846
AN:
4816
European-Finnish (FIN)
AF:
0.183
AC:
1930
AN:
10566
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.166
AC:
11297
AN:
67960
Other (OTH)
AF:
0.168
AC:
355
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1020
2040
3061
4081
5101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.163
Hom.:
9246
Bravo
AF:
0.153
Asia WGS
AF:
0.227
AC:
791
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.6
DANN
Benign
0.66
PhyloP100
0.48
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6464816; hg19: chr7-147226891; API